Active Ingredient(s): Lamivudine, 3TC
FDA Approved: * December 8, 1998
Category: HIV / AIDS

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Epivir-HBV Overview

Lamivudine, commonly called 3TC, is an antiretroviral medication used to prevent and treat HIV/AIDS.[1] It is also used to treat chronic hepatitis B when other options are not possible.[1] It is effective against both HIV-1 and HIV-2.[1] It is typically used in combination with other antiretrovirals such as zidovudine and abacavir.[1] Lamivudine may be included as part of post-exposure prevention in those who have been potentiall...

Read more Epivir-HBV Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Lamivudine

Recent Epivir-HBV Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Lamivudine, 3TC
  • Solution: 10mg/ml, 5mg/ml
  • Tablet: 100mg, 150mg, 300mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Epivir-HBV: (2 results)

Sorted by National Drug Code
  • 0173-0663 Epivir 5 mg/ml Oral Solution by Glaxosmithkline LLC
  • 53808-0893 Epivir 100 mg Oral Tablet, Film Coated by State of Florida Doh Central Pharmacy

Other drugs which contain Lamivudine, 3TC or a similar ingredient: (8 results)

Related Epivir-HBV Topics:

What are the uses ofPantocid Dsr in chronic HBV patients?
Hi sir iam a having hbv from last 5 years but dont have much symptoms but from last few days iam having pain in liver ar... 5 replies
Need Homeo medicine for Chronic Hepatitis B....

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 17 May 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA